<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; Edwards Lifesciences Corp</title>
	<atom:link href="http://www.stockbloghub.com/tag/edwards-lifesciences-corp/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Wed, 23 May 2012 20:22:08 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(ATSI) ATS Medical Gets FDA Approval</title>
		<link>http://www.stockbloghub.com/2009/08/28/atsi-ats-medical-gets-fda-approval/13831</link>
		<comments>http://www.stockbloghub.com/2009/08/28/atsi-ats-medical-gets-fda-approval/13831#comments</comments>
		<pubDate>Fri, 28 Aug 2009 22:49:47 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Ats Medical Inc]]></category>
		<category><![CDATA[ATSI]]></category>
		<category><![CDATA[Edwards Lifesciences Corp]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=13831</guid>
		<description><![CDATA[ATS Medical, Inc. (ATSI) has received approval from the U.S. Food and Drug Administration (FDA) for a landmark clinical study in which cardiac surgeons will implant the company’s ATS 3f Aortic Bioprosthesis valve in a younger aortic valve replacement patient population. The clinical study will be performed to evaluate the effectiveness of ATS 3f Aortic Bioprosthesis valve in a younger population, those less than 60 years of age. The ATS 3f is a tissue valve that functions like a natural valve. It has the same tube shape that helps in maintaining a steady blood flow at a normal speed. Valves are subject to natural wear and tear. The 3f valve is used for replacing a valve in the aorta, the largest blood vessel in the body. ATS Medical is looking ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/08/28/atsi-ats-medical-gets-fda-approval/13831/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

